An add-on is easiest to judge when a study sets the base treatment alone against the base plus the extra. NCBI PMC carries a source that found positive findings in a split‐face study comparing MFU‐V alone to MFU‐V plus HA.
What the study compared
The comparison has two arms, MFU‐V alone and MFU‐V plus HA, which makes the plus HA arm the add-on under test. The AAD guide to firming sagging skin sets out other ways to firm skin, and any extra deserves comparison against those as well.
Reading a positive finding
A positive finding for a combined treatment is the claim an add-on's price leans on. Ask what the finding measured, because positive is a conclusion and the measure behind it is the part a bundle price depends on.
Another view from patients
A retrospective cross-sectional study of patient satisfaction after micro-focused ultrasound with visualization asks how treated patients rated the result. Their ratings are a different kind of evidence from a split-face comparison.
Matching the trial to the product
Ask whether the version a clinic sells matches the plus HA arm or the alone arm, since only one of them carries the extra. A savings figure on a package says nothing about which arm you are actually buying.
A trial on radiofrequency
A pilot study of skin laxity and oiliness after monopolar radiofrequency treatment, using multiple assessment tools covers the radiofrequency side of the question. Its title names two outcomes, laxity and oiliness, so check which of them a clinic's claim relies on.
Questions for the clinic
Ask which study supports the add-on, which arm of it the product matches, and what the add-on costs on its own line. A clinic that can name the study has done the work a headline figure skips.
Does the extra pay back, and for whom?
It pays back for a reader whose product matches the arm that was tested and whose concern matches the outcome that was measured. For anyone else the trial is a reason to ask more questions before paying. The ASDS page on ultrasound therapy for sagging skin is a sensible place to continue reading before the quote is accepted.